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Abstract
The presence of blaSHV-5 is described in a compound transpo-
son, duplicated in tandem and ﬂanked by IS26 copies on a 70-kb
conjugative plasmid (pHNM1), in an Enterobacter cloacae strain
associated with a nosocomial outbreak that occurred in Mexico.
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Enterobacter cloacae has emerged in recent years as an
important nosocomial pathogen in neonatal units, with sev-
eral outbreaks involving strains resistant to expanded-spec-
trum cephalosporins [1]. Although overproduction of
chromosomal AmpC b-lactamase is the mechanism usually
observed, extended-spectrum b-lactamase (ESBL)-producing
E. cloacae are currently increasing [2,3] and several SHV-type
b-lactamases have been described [4].
Previous studies have demonstrated that SHV-5 is the
most frequent ESBL in several enterobacterial species [5–7],
including E. cloacae strain C1177-7 recovered from hospital-
ized patients in Mexico. The present study aimed to charac-
terize the genetic context of SHV-5 in strain C1177-7, which
was isolated during an outbreak in a neonatal unit [8].
Enterobacter cloacae C1177-7 was resistant, according to
CLSI criteria [9], to cefotaxime (16 mg/L), ceftazidime
(256 mg/L) and aztreonam (128 mg/L). This strain trans-
ferred the cefotaxime resistance gene blaSHV-5 on a 70-kb
plasmid (named pHNM1) that contained also blaTEM-1 [8],
with a frequency of 10)3 transconjugants per donor cell.
To determine the genetic context of the SHV-5 gene in
the transconjugant of strain C1177-7, two libraries (2–4 and
4–7 kb) of pHNM1 DNA were constructed and cloned into
the pZErO vector. A total of 576 high-quality readings were
collected and the sequences assembled using PHRED-PHRAP-
CONSED software [10]. (The sequence data reported here are
deposited in the GenBank/EMBL nucleotide database under
accession no. AY532647.1.) The open reading frame (ORF)
prediction and BLASTn and BLASTx analyses identiﬁed a
compound transposon duplicated in tandem (CTDT), which
included the blaSHV-5 gene. This structure was located in a
large contig of 19 958 kb. The ﬁrst two ORFs identiﬁed cor-
responded to the mucA-mucBD operon. The next 9520 bp
corresponded to a compound transposon containing two
IS26 in the same direction with perfect identical terminal
inverted repeats of 14-bp (GGCACTGTTGCAAA) on each
side. These IS26 ﬂanked the ygbMD, fucA, ygbK, ygbJ, deoR,
blaSHV-5, recF and lacYD ORFs.
A third IS26 ﬂanked a duplication of all eight of these
ORFs, which accounted for the remaining 8819 bp of the
main contig generating the CTDT (Fig. 1). PCR fragments
and sequencing obtained from the overlapping ampliﬁed seg-
ments, the entire CTDT, and ﬂanking sequences, corre-
sponded to those expected, and conﬁrmed the structure
(Table 1, Fig. 1). The stability of the CTDT was evaluated by
PCR ampliﬁcation using lacYF-ygbMR-speciﬁc primers (Table 1)
in the C1177-7 strain and its transconjugant after at least ten
bacterial generations in the absence of antibiotic pressure.
The enzyme SHV-5, a plasmid-encoded, broad-spectrum
b-lactamase, was ﬁrst identiﬁed in Klebsiella pneumoniae in
1989 [11]. However, the genetic context of SHV-type b-
lactamase genes was in question for several years [12,13]. In
2004, blaSHV-5 was identiﬁed on a compound transposon
ﬂanked by IS26 insertion sequences in the pACM1 plasmid
(Klebsiella oxytoca) [14], which was obtained from an out-
break in 1993 [15]. Subsequently, the compound transposon
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was found on pSEM (Salmonella enterica) [16] and p1658/97
(Escherichia coli) [17] plasmids. Thus, this compound
transposon has been identiﬁed on plasmids from several bac-
terial species from 1993 (pACM1) to 2007 (p1658/97). It is
worth noting that these were isolated in different geographic
locations (USA – pACM1; Poland – p1658/97; Albania –
pSEM), demonstrating the wide spread of this compound
transposon. It has now been identiﬁed as a tandem duplicate
structure on a 70 kb plasmid (pHNM1) from an E. cloacae
strain associated with a nosocomial outbreak that occurred
in Mexico, a country with a record of earlier outbreaks of
SHV-5-producing Enterobacteriaceae [5,6,18]. The possibility
that this CTDT is related to outbreaks of different bacterial
species, and/or that it is implicated in increased production
of the SHV-5 b-lactamase, cannot be dismissed.
A tandem duplication of a composite transposon via the
insertion sequences (IS600) is associated with increased
toxin (Shiga toxin) production in Shigella dysenteriae [19]. In
plasmid p1658/97, the compound transposon that contains
the blaSHV-5 gene was identiﬁed as an active genetic element.
In addition, under high concentrations of antibiotic, more
copies of the ampliﬁed blaSHV-5 were detected compared to
when lower antibiotic concentrations were used. The over-
production of this enzyme correlated with a compound
transposon structure of 9521 bp ﬂanked by the IS26 inser-
tion sequence [17]. Sequences ﬂanking the SHV-5 gene
in p1658/97 include one ORF of 260 bp (86 amino acids)
that is not present on pHNM1 (AY532647.1) or pSEM
(AJ245670) plasmids. This almost identical region encom-
passes the blaSHV-5 gene and is ﬂanked by two IS26 copies.
The nucleotide sequence comparison between the copies of
this compound transposon on plasmids p1658/97 and pSEM
plasmids revealed high levels of identity (i.e. 99%).
The mechanism of the acquisition of CTDT by pHNM1
suggests recombination as a result of the lack of direct
repeat sequences at the IS26 ends, such as those identiﬁed
in plasmid p1658/97. Duplication in tandem could be charac-
teristic of the IS26 element, which gives rise exclusively to
replicon fusions in which the donor and target replicons are
separated by two directly repeated IS copies, suggesting that
this rearrangement occurred by homologous recombination
between the ﬂanking IS26 sequences in the same orientation
[20]. These rearrangements could comprise a potential
alternative mechanism for generating several copies of the
blaSHV-5 gene on the same plasmid, which can be maintained
as a tandem duplicate for several bacterial generations, as in
the case of pHNM1. The identiﬁcation of the CTDT struc-
ture offers new insights into the mechanism implicated in the
increase of SHV-type gene copy numbers. Future studies are
needed to elucidate genetic rearrangements that generate
tandem ampliﬁcation of the bla-SHV-5 gene carried on com-
pound transposons.
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Compound transposon duplicated in tandem
FIG. 1. Schematic representation of the compound transposon duplicated in tandem (CTDT) harbored on plasmid pHNM1 from the clinical iso-
late Enterobacter cloacae E1177-7. The CTDT carrying the blaSHV-5 gene and seven additional genes duplicated in tandem are ﬂanked by IS26.
Arrows indicate open reading frames; inverted repeats (IR) of 14-bp at the insertion sequence IS26 boundaries are indicated. Approximate PCR
product lengths (kb) are shown in italics. Numbers at both ends of each PCR product indicate the primer pairs used for PCR and sequencing.
TABLE 1. Sequences of primers used in the present study
Target Primera Sequence (5¢–3¢) References
mucB mucBF (1) CCCGTGTACGCCTTAATC Present study
lacY lacYF (2) TGACGCGTTCGATATAAGC Present study
ygbM ygbMR (3) CGGGCTATCTCTACCACAG Present study
SHV-5 P1 (4) ACTGAATGAGGCGCTTCC [21]
blaSHV-5 P2 (5) TCCCGCAGATAAATCACC [21]
blaTEM-1 T1 CAACATTTTCGTGTCGCCC Present study
blaTEM-1 T2 GCTTAATCAGTGAGGCACC Present study
TnpA tnpAR (6) GAGAAGCTTCAGCTGGCGGC Present study
aNumbers in parentheses correspond to the primers used for PCR ampliﬁcation
and sequencing of the compound transposon duplicated in tandem.
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Abstract
External quality assurance for serological detection of chikungunya
virus infection was performed to assess the diagnostic quality of
expert laboratories. Of 30 participants, only six correctly analysed
all reference samples with their respective tests. Thirteen
laboratories gave at least 85% correct results, and 11 laboratories
75% or less. IgM antibodies were detected less frequently than IgG
antibodies (p <0.001). The study provides information on the
quality of different serological tests and indicates that most of the
participants need to improve the sensitivity of their assays, in
particular to detect IgM antibodies more reliably and be able to
detect acute infections adequately.
Keywords: Chikungunya fever, emerging viral infection, external
quality assurance, serology, virus diagnostic
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